Table 2.
Abnormal PET/CT | 33/35 (94.3%) | |||
---|---|---|---|---|
Abnormal 18F-FDG Uptake Site | Number (%) | SUV Available | SUVmax, Mean ± SD |
SUVmax, Range |
Bone marrow | 26/35 (74.3) | 9 | 6.3 ± 1.9 | 3.9–9.0 |
Spleen | 17/35 (48.6) | 13 | 4.2 ± 1.5 | 2.6–7.0 |
Lymph node | ||||
All sites | 26/35 (74.3) | 24 | 7.7 ± 3.9 | 3.3–18.9 |
Supradiaphragmatic | 25/35 (71.4) | 23 | 7.0 ± 3.7 | 2.7–16.3 |
Cervical | 16/35 (45.7) | 12 | 7.4 ± 3.3 | 2.8–13.5 |
Axillary | 15/35 (42.9) | 13 | 6.8 ± 4.5 | 1.6–16.3 |
Mediastinal | 23/35 (65.7) | 19 | 5.7 ± 2.2 | 2.6–10.7 |
Infradiaphragmatic | 17/35 (48.6) | 15 | 7.0 ± 4.4 | 2.8–18.9 |
Abdominal and pelvic | 16/35 (45.7) | 14 | 6.6 ± 4.0 | 2.8–18.9 |
Inguinal | 7/35 (20.0) | 4 | 6.7 ± 5.2 | 2.4–14.0 |
Other areas | ||||
Joint | 3/35 (8.6) | 2 | 6.5 ± 4.7 | 3.1–9.8 |
Lung | 4/35 (11.4) | 1 | 4.5 | |
Muscle | 2/35 (5.7) | 1 | 3.0 |
Reported in one case only: pleura, pericardium, thyroid cartilage, tonsils, stomach, and colon.